Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - MEDICAL ACTION INDUSTRIES INCexh_991.htm
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, DC 20549

 
FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 14, 2013
 

 
Medical Action Industries Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
000-13251
11-2421849
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)
 
500 Expressway Drive South
 
Brentwood, New York
11717
(Address of principal executive offices)
(Zip Code)
 
Registrant’s telephone number, including area code:
(631) 231-4600


Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below):
 
[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
Item 7.01
Regulation FD Disclosure.

On November 14, 2013, Medical Action Industries Inc. (“Medical Action”) made a slide presentation at the Canaccord Genuity Medical Technology and Diagnostics Forum, a copy of which is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.    The presentation materials have been posted on the Investor Relations section of Medical Action’s website at www.medical-action.com.
 
The information in this Current Report on Form 8-K under this Item 7.01 (including Exhibit 99.1 hereto) is being “furnished” and shall not be deemed to be “filed” for the purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of the Exchange Act, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.  The information included in this Current Report on Form 8-K under this Item 7.01 (including Exhibit 99.1 hereto) will not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.

Item 9.01
Financial Statements and Exhibits.

(d) Exhibits

99.1
 
Canaccord Genuity Medical Technology and Diagnostics Forum Presentation Materials

 
 



 
 

 
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


  MEDICAL ACTION INDUSTRIES INC.
     
     
     
  By:
/s/ Brian Baker                                                      
   
Brian Baker
   
Vice President of Finance and
Principal Accounting Officer
     


Dated:    November 14, 2013